Balaxi Pharmaceuticals Ltd (BALX)

Currency in INR
47.50
+0.30(+0.64%)
Closed·
BALX Scorecard
Full Analysis
Trading at a low Price / Book multiple
Trading near 52-week Low
Fair Value
Day's Range
44.4148.38
52 wk Range
44.41127.45
Key Statistics
Bid/Ask
47.65 / 47.70
Prev. Close
47.2
Open
46.5
Day's Range
44.41-48.38
52 wk Range
44.41-127.45
Volume
533.12K
Average Volume (3m)
360.54K
1-Year Change
-57.37%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BALX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell

Balaxi Pharmaceuticals Ltd Company Profile

Balaxi Pharmaceuticals Limited engages in the international wholesale distribution of pharmaceuticals, builders hardware, and FMCG products in India and internationally. The company offers pharmaceutical products across various therapeutic areas that mainly treats antibiotics, analgesic, anti-malaria, and others. It also provides biscuits and toothpastes. The company was formerly known as Balaxi Ventures Limited and changed its name to Balaxi Pharmaceuticals Limited in October 2020. The company was incorporated in 1942 and is headquartered in Hyderabad, India. Balaxi Pharmaceuticals Limited is a subsidiary of Balaxi Overseas Private Limited.

Employees
600
Market
India

Compare BALX to Peers and Sector

Metrics to compare
BALX
Peers
Sector
Relationship
P/E Ratio
10.4x49.0x−0.5x
PEG Ratio
0.01−1.100.00
Price/Book
1.1x2.1x2.6x
Price / LTM Sales
0.9x1.7x3.3x
Upside (Analyst Target)
-60.1%42.8%
Fair Value Upside
Unlock12.7%6.5%Unlock

Earnings

Latest Release
May 30, 2025
EPS / Forecast
1.56 / --
Revenue / Forecast
745.73M / --
EPS Revisions
Last 90 days

BALX Income Statement

People Also Watch

203.48
IGAS
-1.64%
2,242.80
COLG
+0.55%
3,520.00
TORP
-1.93%
917.00
NATP
-1.58%
3,629.80
CUMM
+1.07%

FAQ

What Stock Exchange Does Balaxi Pharmaceuticals Trade On?

Balaxi Pharmaceuticals is listed and trades on the India National Stock Exchange stock exchange.

What Is the Stock Symbol for Balaxi Pharmaceuticals?

The stock symbol for Balaxi Pharmaceuticals is "BALX."

What Is the Balaxi Pharmaceuticals Market Cap?

As of today, Balaxi Pharmaceuticals market cap is 2.63B.

What Is Balaxi Pharmaceuticals's Earnings Per Share (TTM)?

The Balaxi Pharmaceuticals EPS (TTM) is 4.54.

From a Technical Analysis Perspective, Is BALX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Balaxi Pharmaceuticals Stock Split?

Balaxi Pharmaceuticals has split 1 times.

How Many Employees Does Balaxi Pharmaceuticals Have?

Balaxi Pharmaceuticals has 600 employees.

What is the current trading status of Balaxi Pharmaceuticals (BALX)?

As of 06 Aug 2025, Balaxi Pharmaceuticals (BALX) is trading at a price of 47.50, with a previous close of 47.20. The stock has fluctuated within a day range of 44.41 to 48.38, while its 52-week range spans from 44.41 to 127.45.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.